Category Archives: Healthcare

The SVP of Dynavax is Exercising Options

Today, the SVP of Dynavax, Robert Coffman, exercised options of Dynavax for $141.8K. The company has a one-year high of $24.45 and a one-year low of $3.70. Currently, Dynavax has an average volume of 3.65M. Based on 3 analyst ratings,

The VP Technical Affairs – APT of Acura Pharmaceuticals (NASDAQ: ACUR) is Buying Shares

Today, the VP Technical Affairs – APT of Acura Pharmaceuticals (NASDAQ: ACUR), Albert Brzeczko, bought shares of ACUR for $30K. Following this transaction Albert Brzeczko’s holding in the company was increased by 1875% to a total of $107.4K. In addition

Friday’s Midday Movers: OHR Pharmaceutical (OHRP), ImmunoCellular Therapeutics (IMUC), Galena Biopharma (GALE), Pixelworks (PXLW), Terra Tech Corp (TRTC)

So far Friday, December 15, NASDAQ is up 1.59% and the S&P is up 1.12%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; OHR Pharmaceutical (NASDAQ:OHRP), ImmunoCellular Therapeutics (NYSE MKT:IMUC), Galena Biopharma (NASDAQ:GALE),

The SVP of Waters Corp is Exercising Options

Today, the SVP of Waters Corp, Eugene Cassis, exercised options of Waters Corp for $4.71M. Following Eugene Cassis’ last WAT Sell transaction on June 06, 2017, the stock climbed by 10.4%. In addition to Eugene Cassis, 3 other WAT executives

Cantor Fitzgerald Issues a Buy Rating on Aclaris Therapeutics Inc

Cantor Fitzgerald analyst Louise Chen assigned a Buy rating to Aclaris Therapeutics Inc (NASDAQ: ACRS) today and set a price target of $50. The company’s shares closed yesterday at $24.72. Chen wrote: “ACRS received approval for Eskata to treat SK.

Analysts Offer Insights on Healthcare Companies: Teva Pharma (NYSE: TEVA) and Orasure Technologies (NASDAQ: OSUR)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teva Pharma (NYSE: TEVA) and Orasure Technologies (NASDAQ: OSUR). Teva Pharma (NYSE: TEVA) Raymond James analyst Elliot Wilbur assigned a Hold rating to